• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留的心力衰竭门诊患者肺部超声检查中的肺淤血情况

Pulmonary Congestion on Lung Ultrasound in Ambulatory Patients With Heart Failure With Preserved Ejection Fraction.

作者信息

Platz Elke, McDowell Kirsty, Gupta Deepak K, Claggett Brian, Brennan Alice, Charles Lawrence J, Cunningham Jonathan W, Dixon Debra D, Docherty Kieran F, Jering Karola, Oggs Rashundra, Palacios Julia, Schwede Madeleine, Ravi Katherine Scovner, Sukumar Shivasankar M, Wassenaar Jean W, Lewis Eldrin F, McMurray John J V, Campbell Ross T

机构信息

Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.

British Heart Foundation Glasgow Cardiovascular Research Centre, School of Cardiovascular & Metabolic Health, University of Glasgow, Glasgow, UK.

出版信息

J Card Fail. 2025 Mar 5. doi: 10.1016/j.cardfail.2025.02.013.

DOI:10.1016/j.cardfail.2025.02.013
PMID:40054838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12353334/
Abstract

BACKGROUND

Early detection of pulmonary congestion among ambulatory patients with heart failure with preserved ejection fraction (HFpEF) is critical to optimize decongestive therapy before overt decompensation, yet traditional tools are insensitive. We sought to examine the prevalence of B-lines, an ultrasound measure of pulmonary congestion, and their clinical and imaging correlates in patients with HFpEF.

METHODS AND RESULTS

In a prospective, multisite observational study, using a pocket ultrasound device, 8-zone lung ultrasound examination was performed in outpatients with HFpEF, left ventricular ejection fraction (LVEF) of ≥45% and New York Heart Association functional class II through IV. B-lines and cardiac structure and function from echocardiograms were quantified off-line in core laboratories, blinded to clinical findings. Among 415 participants (mean age 74 years, 52% women, 51% obese, median N-terminal pro-B-type natriuretic peptide [NT-proBNP] 744 pg/mL) B-lines were detectable in 78% of patients ranging from 0 to 36 (median 3, interquartile range 1-6). There was a linear association between B-line count and log-transformed NT-proBNP (P < .001). Among patients in the highest tertile of B-lines, 76% had no crackles on auscultation, and 50% did not have elevated NT-proBNP levels. A higher B-line count was associated with larger sizes of cardiac chambers, greater left ventricular mass, higher filling pressures (E/e'), tricuspid regurgitant velocity, and inferior vena cava size, and worse right ventricular systolic function (P for trend < .05 for all), but not left ventricular ejection fraction.

CONCLUSIONS

Among ambulatory patients with HFpEF, lung ultrasound-detected B-lines were common, associated with NT-proBNP levels and clinically important echocardiographic features, and identified pulmonary congestion that was not always evident by auscultation.

摘要

背景

对于射血分数保留的心力衰竭(HFpEF)门诊患者,早期发现肺充血对于在明显失代偿前优化去充血治疗至关重要,但传统工具不够敏感。我们试图研究B线(一种肺充血的超声测量指标)的患病率及其在HFpEF患者中的临床和影像学相关性。

方法与结果

在一项前瞻性、多中心观察性研究中,使用便携式超声设备,对HFpEF、左心室射血分数(LVEF)≥45%且纽约心脏协会功能分级为II至IV级的门诊患者进行8区肺部超声检查。在核心实验室对超声心动图中的B线以及心脏结构和功能进行离线定量分析,分析人员对临床结果不知情。在415名参与者(平均年龄74岁,52%为女性,51%肥胖,N末端B型利钠肽原[NT-proBNP]中位数为744 pg/mL)中,78%的患者可检测到B线,数量范围为0至36条(中位数为3条,四分位间距为1 - 6条)。B线计数与经对数转换的NT-proBNP之间存在线性关联(P < .001)。在B线处于最高三分位数的患者中,76%的患者听诊时无啰音,50%的患者NT-proBNP水平未升高。较高的B线计数与较大的心脏腔室大小、更大的左心室质量、更高的充盈压(E/e')、三尖瓣反流速度和下腔静脉大小以及更差 的右心室收缩功能相关(所有趋势P < .05),但与左心室射血分数无关。

结论

在HFpEF门诊患者中,肺部超声检测到的B线很常见,与NT-proBNP水平及重要的超声心动图特征相关,并可发现听诊时并不总是明显的肺充血。

相似文献

1
Pulmonary Congestion on Lung Ultrasound in Ambulatory Patients With Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭门诊患者肺部超声检查中的肺淤血情况
J Card Fail. 2025 Mar 5. doi: 10.1016/j.cardfail.2025.02.013.
2
Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting.利钠肽在门诊环境中评估射血分数保留的慢性心力衰竭中的循证应用
Circulation. 2025 Apr 8;151(14):976-989. doi: 10.1161/CIRCULATIONAHA.124.072156. Epub 2025 Jan 22.
3
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction.沙库巴曲缬沙坦治疗起始后N末端前B型利钠肽的变化与射血分数降低的心力衰竭患者心脏结构和功能的关联
JAMA. 2019 Sep 17;322(11):1085-1095. doi: 10.1001/jama.2019.12821.
4
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial.射血分数正常和超常的心力衰竭患者的心肌肌球蛋白抑制作用:EMBARK-HFpEF试验的主要结果
JAMA Cardiol. 2025 Feb 1;10(2):170-175. doi: 10.1001/jamacardio.2024.3810.
5
Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction.探索代谢合并症对射血分数保留的心力衰竭患者心外膜脂肪组织的影响。
Cardiovasc Diabetol. 2025 Mar 22;24(1):134. doi: 10.1186/s12933-025-02688-7.
6
Impact of iron deficiency on congestion and postdischarge survival in patients recently hospitalised for decompensated heart failure: a multicentre, prospective, observational analysis of the FERIC-RO study.缺铁对近期因失代偿性心力衰竭住院患者充血情况及出院后生存的影响:FERIC-RO研究的多中心、前瞻性观察分析
Open Heart. 2025 Feb 27;12(1):e002851. doi: 10.1136/openhrt-2024-002851.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
The Effect of Weight Loss Through Lifestyle Interventions in Patients With Heart Failure With Preserved Ejection Fraction-A Systematic Review and Meta-Analysis of Randomised Controlled Trials.生活方式干预对射血分数保留心力衰竭患者体重减轻的影响:一项随机对照试验的系统评价和荟萃分析。
Heart Lung Circ. 2024 Feb;33(2):197-208. doi: 10.1016/j.hlc.2023.11.022. Epub 2024 Feb 6.
9
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.
10
Exploring heart failure prevalence and dimensions: A comprehensive NT-proBNP study in high-risk primary care patients.探索心力衰竭的患病率及维度:一项针对高危初级保健患者的NT-proBNP综合研究。
ESC Heart Fail. 2025 Aug;12(4):2834-2842. doi: 10.1002/ehf2.15290. Epub 2025 Jun 2.

本文引用的文献

1
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America.《2024年心力衰竭统计数据:美国心力衰竭学会2024年更新报告》
J Card Fail. 2025 Jan;31(1):66-116. doi: 10.1016/j.cardfail.2024.07.001. Epub 2024 Sep 24.
2
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.非奈利酮治疗射血分数轻度降低或保留的心力衰竭。
N Engl J Med. 2024 Oct 24;391(16):1475-1485. doi: 10.1056/NEJMoa2407107. Epub 2024 Sep 1.
3
Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure.急性心力衰竭患者心力衰竭再入院和全因死亡率的预测因素。
Int J Cardiol. 2024 Jul 1;406:132036. doi: 10.1016/j.ijcard.2024.132036. Epub 2024 Apr 8.
4
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.司美格鲁肽与安慰剂治疗射血分数保留的肥胖相关性心力衰竭患者的比较:STEP-HFpEF和STEP-HFpEF DM随机试验的汇总分析
Lancet. 2024 Apr 27;403(10437):1635-1648. doi: 10.1016/S0140-6736(24)00469-0. Epub 2024 Apr 7.
5
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.《2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》2023年聚焦更新
Eur Heart J. 2023 Oct 1;44(37):3627-3639. doi: 10.1093/eurheartj/ehad195.
6
Lung ultrasound in acute and chronic heart failure: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI).急性和慢性心力衰竭中的肺部超声:欧洲心血管影像学会(EACVI)临床共识声明
Eur Heart J Cardiovasc Imaging. 2023 Nov 23;24(12):1569-1582. doi: 10.1093/ehjci/jead169.
7
Trajectory and correlates of pulmonary congestion by lung ultrasound in patients with acute myocardial infarction: insights from PARADISE-MI.肺超声评估急性心肌梗死患者肺淤血的轨迹及其相关因素:PARADISE-MI 研究的见解。
Eur Heart J Acute Cardiovasc Care. 2023 Apr 3;12(3):155-164. doi: 10.1093/ehjacc/zuad001.
8
Health-related quality of life in acute heart failure: association between patient-reported symptoms and markers of congestion.急性心力衰竭患者的健康相关生活质量:患者报告的症状与充血标志物之间的关系。
Eur J Heart Fail. 2023 Jan;25(1):54-60. doi: 10.1002/ejhf.2699. Epub 2022 Oct 14.
9
Lung ultrasound-guided treatment for heart failure: An updated meta-analysis and trial sequential analysis.肺超声引导下治疗心力衰竭:一项更新的荟萃分析和试验序贯分析
Front Cardiovasc Med. 2022 Aug 22;9:943633. doi: 10.3389/fcvm.2022.943633. eCollection 2022.
10
Lung ultrasound findings following COVID-19 hospitalization: A prospective longitudinal cohort study.COVID-19 住院后肺部超声表现:一项前瞻性纵向队列研究。
Respir Med. 2022 Jun;197:106826. doi: 10.1016/j.rmed.2022.106826. Epub 2022 Apr 2.